Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000

AIDS

Volumn 14, Issue 8, 2000, Pages 1017-1026

  Dabis, François ^a   Leroy, Valériane ^a   Castetbon, Katia ^a   Spira, Rosemary ^a   Newell, Marie Louise ^b   Salamon, Roger ^a  

^a INSERM   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Africa; HIV; Mother to child transmission; Prevention; Public health

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

AFRICA; ANTISEPSIS; ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DEVELOPING COUNTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; MOTHER; PRIORITY JOURNAL; PROGENY; RANDOMIZED CONTROLLED TRIAL; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

AFRICA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034119119     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200005260-00014     Document Type: Article

References (75)

1. 1. UNAIDS. AIDS epidemic update. December 1998. Available from: URL http://vvww.unaids.org/unaids/document/epidemio/ wadr98e.pdf.
2. 2. UNICEF. 1999 Progress of Nations, http://www.unicef.org/pon99.
3. 3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
4. 4. Shaffer N, Chuachoowong R, Mock PA, et al. Randomized placebo-controlled trial of short-course antenatal zidovudine to reduce perinatal HIV transmission, Bangkok, Thailand. Lancet 1999, 353:773-780.
5. 5. World Health Organization. Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV. Wkly Epidemiol Rec 1998, 73: 313-320.
6. 6. Dabis F, Mandelbrot L, Msellati P, Van de Perre P. Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries? AIDS 1995, 9:204-206.
7. 7. Lallemant M, Jourdain G, Kim S, et al. Perinatal HIV Prevention Trial (PHPT), Thailand: DSMB recommends termination of short-short arm after first interim analysis. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 016].
8. 8. Wiktor SZ, Ekpini ER, Karon JM, et al. Randomized clinical trial of a short course of oral zidovudine to prevent mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet 1999, 353:781-785.
9. 9. Dabis F, Msellati P, Meda N, et al. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso; a double-blind placebo-controlled multicentre trial. Lancet 1999, 353:786-792.
10. 10. DITRAME Study Group. 15 months efficacy of a maternal short regimen of oral zidovudine to reduce vertical transmission of HIV in African breast-fed children. Lancet 1999, 354: 2050-2051.
11. 11. Saba J. The results of the PETRA intervention trial to prevent perinatal transmission in SubSaharan Africa. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, February 1999 [Abstract S6].
12. 12. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795-802.
13. 13. Musoke P, Guay LA, Bagenda D, et al. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS 1999, 13:479-486.
14. 14. Biggar JR, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996, 347:1647-1650.
15. 15. Taha TE, Biggar RJ, Broadhead RL, et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997, 315:216-220.
16. 16. Gaillard P, Mwanyumba F, Verhofstede C, et al. Birth canal lavage with chlorhexidine during labour to reduce mother to child HIV transmission: clinical trial in Mombasa, Kenya. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 249].
17. 17. Msellati P, Meda N, Leroy V, et al. Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV-infected pregnant women in West Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. Sex Transm Infect 1999, in press.
18. 18. Semba R. Nutritional interventions: vitamin A and breast-feeding. 3rd International Symposium: Global Strategies to Prevent Perinatal HIV-1 Transmission. Valencia, November 1998.
19. 19. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM, for the South African Vitamin A Study Group. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 1999, 13:1517-1524.
20. 20. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM, for the South African Vitamin A Study Group. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa. Lancet 1999, 354:471-476.
21. 21. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1 infected women in Tanzania. Lancet 1998, 351:1477-1482.
22. 22. Fawzi W. Micronutrients and HIV transmission. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 051].
23. 23. Nduati R, John G, Ngacha DA, et al. Breastfeeding transmission of HIV-1: a randomized clinical trial. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 13ET5-2].
24. 24. CDC, UNAIDS, NIH and ANRS. Joint statement following the announcement by the Ministry of Public Health of Thailand and the CDC of results from their mother-to-child transmission trial. Press release. February 1998.
25. 25. Dabis F, Msellati P, Dunn D, et al. Estimating the rate of mother-to-child transmission of HIV: Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. AIDS 1993, 7:1139-1148.
26. 26. The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. J Acquired Immune Defic Syndr Hum Retrovirol 1995, 8:506-510.
27. 27. Dabis F, Msellati P, Newell M-L, et al. Methodology of intervention trials to reduce mother to child transmission of HIV with special reference to developing countries. AIDS 1995, 9 (Suppl. A):S67-S74.
28. 28. Diaby L, Sibailly TS, Ekpini ER, et al. Effectiveness of a short-course oral zidovudine regimen in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: long-term follow-up in a breast-feeding population. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 15PT38-90].
29. 29. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998, 339: 1409-1414.
30. 30. Bulterys M, Orloff S, Abrams E, et al. Impact of zidovudine post-perinatal exposure prophylaxis on vertical HIV-1 transmission: a prospective cohort study in 4 U.S. cities. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 015].
31. 31. Van de Perre P. Mother-to-child transmission of HIV-1: the 'all mucosal' hypothesis as a predominant mechanism of transmission. AIDS 1999, 13:1133-1138.
32. 32. Centers for Disease Control and Prevention. Public Health Service Guidelines for the management of health-care worker exposures to HIV and recommendations for post-exposure prophylaxis. MMWR 1998, 47 (RR-7):1-28.
33. 33. Blanche S, Rouzioux C, Mandelbrot L, et al. Zidovudine-lamivudine for prevention of mother to child HIV-1 transmission. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, February 1999 [Abstract 267].
34. 34. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999, 354:1084-1089.
35. 35. Smith ME and the US Nucleoside Safety Review Working Group. Ongoing nucleoside safety review of HIV exposed children in US studies. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 096].
36. 36. Brinkman K, ter Hofstede HJM, Burger DM, Smeitlink JAM, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998, 12:1735-1744.
37. 37. Leroy V, Meda N, Ramon R, et al. Postnatal HIV transmission risk in a trial assessing the efficacy of a short regimen of oral zidovudine (ZDV) in West Africa. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 15ET3-4].
38. 38. Leroy V, Newell ML, Dabis F, et al. Late postnatal mother-to-child transmission of HIV-1: an international multicentre pooled analysis. Lancet 1998, 352:597-600.
39. 39. Miotti PG, Taha TET, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999, 282:744-749.
40. 40. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999, 180:93-98.
41. 41. Willumsen J, Filteau SM, Coutsoudis A, et al. Subclinical mastitis and breastmilk viral load among lactating women infected with HIV-1 in South Africa. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 210].
42. 42. World Health Organization. HIV and infant feeding. Guidelines for decision makers. Geneva: WHO/FRH/NUT/CHD 98.1; 1998.
43. 43. World Health Organization. HIV and infant feeding. A guide for health care managers and supervisors. Geneva: WHO/FRH/NUT/ CHD 98.4; 1998.
44. 44. World Health Organization. Integration of vitamin A supplementation with immunization. Wkly Epidemiol Rec 1999, 74:1-6.
45. 45. Semba R. Breast-feeding, mastitis, and HIV transmission: nutritional implications. Nutr Rev 1999, 57:146-153.
46. 46. Ladner, J, Leroy, V, Huffman, P, et al. Chorioamnionitis and pregnancy outcome in HIV infected African women. J Acquired Immune Defic Syndr Hum Retrovirol 1998, 18:293-298.
47. 47. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type I in women treated with zidovudine. N Engl J Med 1999, 341:385-393.
48. 48. Goldenberg RL, Vermund SH, Goepfert AR, Andrews WW. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission? Lancet 1998, 352:1927-1930.
49. 49. Goldenberg RL. Chorioamnionitis, preterm birth, membrane rupture and maternal-infant HIV transmission. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 103].
50. 50. UNAIDS. Prevention of HIV transmission from mother to child. Planning for programme implementation. Report from a meeting, Geneva, 23-24 March 1998. Available from: URL http://www. unaids.org/highband/document/mother-to-child/index.html.
51. 51. Wilfert C, Hirsch, MS, Ammann, A, et al. IAS position paper on prevention of HIV-1 mother-to-child transmission. AIDS 1999, 13:A5-A9.
52. 52. Dabis F, Newell ML, Fransen L, et al. Prevention of mother-to-child transmission of HIV in developing countries: from research to standard care. Health Policy Planning 2000, 15:34-42.
53. 53. UNAIDS. Prevention of HIV transmission from mother-to-child. Strategic options. UNAIDS/99.40E. Geneva: UNAIDS; 1999.
54. 54. World Health Organisation. HIV in pregnancy: a review. Occasional Paper Number 2. WHO/CHS/RHR/99.15; UNAIDS/ 99.35E. Geneva: World Health Organisation; 1999.
55. 55. Marseille E, Kahn JG, Mmiro F, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999, 354:803-809.
56. 56. Mercier E. Status of implementation of pilot projects for the prevention of perinatal HIV transmission. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 012].
57. 57. Balter M. HIV - French-led therapy fund kicks off in Africa. Science 1999, 284:1101.
58. 58. Welffens-Ekra C, Hingst G, Msellati P, et al. A pilot programme of reduction of HIV transmission from mother to infants in Abidjan, Côte d'Ivoire, 1998-1999. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, September 1999 [Abstract 097].
59. 59. Stover J, Bollinger L. A cost-effectiveness model to analyze alternative strategies to prevent mother-to-child transmission of HIV. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 15ET3-6].
60. 60. Newell ML, Dabis F, Tolley K, Whyne D. Cost-effectiveness and cost benefit in the prevention of mother-to-child transmission of HIV in developing countries. AIDS 1998, 12:1571-1580.
61. 61. Giraudon I, Leroy V, Msellati P, et al. Medical care costs of HIV-infected children included in a trial in Abidjan, Côte d'Ivoire, 1996-1997. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 13PT21-3].
62. 62. Cartoux M, Meda N, Van de Perre P, et al. Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey, 1997. AIDS 1998, 12:2489-2493.
63. 63. Cartoux, M, Msellati, P, Meda, N, et al. Attitude of pregnant women towards HIV testing in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso. AIDS 1998, 12:2337-2344.
64. 64. Msellati P, Ramon R, Viho I, et al. Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire. AIDS 1998, 12: 1257-1258.
65. 65. Temmerman M, Ndinya-Achola J, Ambani J, Piot P. The right not to know HIV test results. Lancet 1995, 345:969-970.
66. 66. Graham WJ, Newell ML. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. Lancet 1999, 353:836-839
67. 67. Spira R, Lepage P, Msellati P, et al. Natural history of HIV type 1 infection in children: a five year prospective study in Rwanda. Pediatrics 1999, 104: URL: pediatrics.org/cgi/content/full/104/57 e56.
68. 68. Dabis F, Meda N, Msellati P, et al. Infant mortality in African children included in a trial assessing the efficacy of a maternal short regimen of oral zidovudine (ZDV) in West Africa. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 15PT38-91].
69. 69. Lepage P, Spira R, Kalibala S, et al. Care of HIV-infected children in developing countries: report of a workshop for clinical research. Paris, September 26-27, 1997. Pediatr Infect Dis J 1998, 17:581-586.
70. 70. Ansari NA, Kombe AH, Kenyon TA, et al. Mortality and pulmonary pathology of children with HIV infection in Francistown, Botswana. XIth International Conference on AIDS and STDs in Africa. Lusaka, September 1999 [Abstract 13ET5-4].
71. 71. Soderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ 1999, 318:1650-1656.
72. 72. Onyango AW, Esrey SA, Kramer MS. Continued breast-feeding and child growth in the second year of life: a prospective cohort study in Western Kenya. Lancet 1999, 354:2041-2045.
73. 73. Perinatal HIV Intervention Research in Developing Countries Workshop Participants. Science, ethics, and the future of research into maternal infant transmission of HIV-1. Lancet 1999, 353:832-835.
74. 74. Wilkinson D, Karim, SSA, Coovadia HM. Short course antiretroviral regimens to reduce maternal transmission of HIV - May be effective but shouldn't be allowed to strangle research that might help Africans BMJ 1999, 318:479-480.
75. 75. Msellati P, Meda N, Welffens-Ekra C, et al. Zidovudine and reduction of HIV vertical transmission in Africa. Am J Public Health 1999, 89:947-948.